Product Details
Apretude 600 mg Prolonged-release Suspension for Injection
Cabotegravir600 mg
Suspension for injection
ROA
Intramuscular
Applicant Name
Glaxo Smithkline Consumer Nigeria PLC
NRN
A4-100537
Status
Active
Composition
ATC Code
J05AJ04
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1vial,1vialx25
Product Description
31 NF-PP-335639 Apretude 600 mg Prolonged-release Suspension for Injection Cabotegravir Cabotegravir 600 mg, Mannitol (E421) Polysorbate 20 (E432) Macrogol (E1521) Water for injections Drugs Imported Products 1vial,1vial*25 Prescription Only Medicine (POM) 6/22/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 regulatorypharma-ng@gsk.com Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations) , Harmire Road Barnard Castle Co. Durham DL12 8DT United Kingdom, United Kingdom
Manufacturer Name
Glaxo Operations UK Limited
Manufacturer Country
UNITED KINGDOM
Approval Date
2023-09-28
Expiry Date
2028-09-27